Israel's Teva seeks partners to fund some drug development

JERUSALEM, Aug 16 (Reuters) - Teva Pharmaceutical Industries said on Wednesday it was looking into a series of partnerships to fund some projects in its drug development pipeline, as the drugmaker seeks to pay down more than $5 billion of debt this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.